Skip to main content
Erschienen in: Endocrine 2/2021

12.01.2021 | Original Article

Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register)

verfasst von: Jessica Pepe, Pasquale Agosti, Cristiana Cipriani, Mauro Tettamanti, Alessandro Nobili, Luciano Colangelo, Rachele Santori, Mirella Cilli, Salvatore Minisola, Reposi investigators

Erschienen in: Endocrine | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate clinical features, treatments, and outcomes of osteoporotic patients admitted to internal medicine and geriatric wards compared with non-osteoporotic patients (REPOSI registry).

Methods

We studied 4714 patients hospitalized between 2010 and 2016. We reported age, sex, educational level, living status, comorbidities and drugs taken, Cumulative Illness Rating Scale (CIRS), Barthel Index, Short-Blessed Test, 4-item Geriatric Depression Scale, serum hemoglobin, creatinine, and clinical outcomes. Osteoporosis was defined based on the diagnoses recorded at admission, according to the following ICD9: 733, 805–813, 820–823.

Results

Twelve percent of the patients had a preadmission diagnosis of osteoporosis. Only 20% of these had been prescribed oral bisphosphonates; 34% were taking vitamin D supplements. Osteoporotic patients were significantly older, with lower BMI, higher CIRS, and taking more drugs. They were significantly more depressed, less independent, with a higher severity of cognitive impairment compared with non-osteoporotic patients. At discharge, the number of patients receiving treatment for osteoporosis did not change. Length of stay and inhospital mortality did not differ between groups. Osteoporotic patients were more frequently nonhome discharged compared with those without osteoporosis (14.8 vs. 7.9%, p = 0.0007), mostly discharged to physical therapy or rehabilitation (8.8 vs. 2.5% of patients, p < 0.0001). Among osteoporotic patients deceased 3 months after discharge, the number of those treated with vitamin D, with or without calcium supplements, was significantly lower compared with survivors (12 vs. 32%, p = 0.0168).

Conclusions

The diagnosis of osteoporosis is poorly considered both during hospital stay and at discharge; osteoporotic patients are frailer compared to non-osteoporotic patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat E. Hernlund, A. Svedbom, M. Ivergård, J. Compston, C. Cooper, J. Stenmark, E.V. McCloskey, B. Jönsson, J.A. Kanis, Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the international osteoporosis foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch. Osteoporos. 8, 136 (2013)CrossRef E. Hernlund, A. Svedbom, M. Ivergård, J. Compston, C. Cooper, J. Stenmark, E.V. McCloskey, B. Jönsson, J.A. Kanis, Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the international osteoporosis foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch. Osteoporos. 8, 136 (2013)CrossRef
2.
Zurück zum Zitat P.D. Miller, Underdiagnosis and undertreatment of osteoporosis: the battle to be won. J. Clin. Endocrinol. Metab. 101, 852–859 (2016)CrossRef P.D. Miller, Underdiagnosis and undertreatment of osteoporosis: the battle to be won. J. Clin. Endocrinol. Metab. 101, 852–859 (2016)CrossRef
3.
Zurück zum Zitat J. Flais, G. Coiffier, J. Le Noach, J.D. Albert, M. Faccin, A. Perdriger, H. Thomazeau, P. Guggenbuhl, Low prevalence of osteoporosis treatment in patients with recurrent major osteoporotic fracture. Arch. Osteoporos. 12, 24 (2017)CrossRef J. Flais, G. Coiffier, J. Le Noach, J.D. Albert, M. Faccin, A. Perdriger, H. Thomazeau, P. Guggenbuhl, Low prevalence of osteoporosis treatment in patients with recurrent major osteoporotic fracture. Arch. Osteoporos. 12, 24 (2017)CrossRef
4.
Zurück zum Zitat S. Gonnelli, C. Caffarelli, G. Iolascon, F. Bertoldo, G.L. Mauro, A. Patti, R. Nuti, Prescription of anti-osteoporosis medications after hospitalization for hip fracture: a multicentre Italian survey. Aging Clin. Exp. Res. 29, 1031–1037 (2017)CrossRef S. Gonnelli, C. Caffarelli, G. Iolascon, F. Bertoldo, G.L. Mauro, A. Patti, R. Nuti, Prescription of anti-osteoporosis medications after hospitalization for hip fracture: a multicentre Italian survey. Aging Clin. Exp. Res. 29, 1031–1037 (2017)CrossRef
5.
Zurück zum Zitat K. Johnell, J. Fastbom, Undertreatment of osteoporosis in the oldest old? A nationwide study of over 700,000 older people. Arch. Osteoporos. 4, 17–23 (2009)CrossRef K. Johnell, J. Fastbom, Undertreatment of osteoporosis in the oldest old? A nationwide study of over 700,000 older people. Arch. Osteoporos. 4, 17–23 (2009)CrossRef
6.
Zurück zum Zitat O. Strom, F. Borgstrom, S.S. Sen, S. Boonen, P. Haentjens, O. Johnell, J.A. Kanis, Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries—an economic evaluation based on the fracture intervention trial. Osteoporos. Int. 18, 1047–1061 (2007)CrossRef O. Strom, F. Borgstrom, S.S. Sen, S. Boonen, P. Haentjens, O. Johnell, J.A. Kanis, Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries—an economic evaluation based on the fracture intervention trial. Osteoporos. Int. 18, 1047–1061 (2007)CrossRef
7.
Zurück zum Zitat M.T. Puth, M. Klaschik, M. Schmid, K. Weckbecker, E. Münster, Prevalence and comorbidity of osteoporosis- a cross-sectional analysis on 10,660 adults aged 50 years and older in Germany. BMC Musculoskelet. Disord. 19, 144 (2018)CrossRef M.T. Puth, M. Klaschik, M. Schmid, K. Weckbecker, E. Münster, Prevalence and comorbidity of osteoporosis- a cross-sectional analysis on 10,660 adults aged 50 years and older in Germany. BMC Musculoskelet. Disord. 19, 144 (2018)CrossRef
8.
Zurück zum Zitat J.P. Gutzwiller, J.P. Richterich, Z. Stanga, U.E. Nydegger, L. Risch, M. Risch, Osteoporosis, diabetes, and hypertension are major risk factors for mortality in older adults: an intermediate report on a prospective survey of 1467 community-dwelling elderly healthy pensioners in Switzerland. BMC Geriatr. 18, 115 (2018)CrossRef J.P. Gutzwiller, J.P. Richterich, Z. Stanga, U.E. Nydegger, L. Risch, M. Risch, Osteoporosis, diabetes, and hypertension are major risk factors for mortality in older adults: an intermediate report on a prospective survey of 1467 community-dwelling elderly healthy pensioners in Switzerland. BMC Geriatr. 18, 115 (2018)CrossRef
9.
Zurück zum Zitat I.D. Cameron, J.S. Chen, L.M. March, J.M. Simpson, R.G. Cumming, M.J. Seibel, P.N. Sambrook, Hip fracture causes excess mortality owing to cardiovascular and infectious disease in institutionalized older people: a prospective 5-year study. J. Bone Miner. Res. 25, 866–872 (2010)PubMed I.D. Cameron, J.S. Chen, L.M. March, J.M. Simpson, R.G. Cumming, M.J. Seibel, P.N. Sambrook, Hip fracture causes excess mortality owing to cardiovascular and infectious disease in institutionalized older people: a prospective 5-year study. J. Bone Miner. Res. 25, 866–872 (2010)PubMed
10.
Zurück zum Zitat L. Bondo, P. Eiken, B. Abrahamsen, Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients-a nationwide register-based open cohort study. Osteoporos. Int. 24, 245–252 (2013)CrossRef L. Bondo, P. Eiken, B. Abrahamsen, Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients-a nationwide register-based open cohort study. Osteoporos. Int. 24, 245–252 (2013)CrossRef
11.
Zurück zum Zitat L.A. Beaupre, D.W. Morrish, D.A. Hanley, W.P. Maksymowych, N.R. Bell, A.G. Juby, S.R. Majumdar, Oral bisphosphonates are associated with reduced mortality after hip fracture. Osteoporos. Int. 22, 983–991 (2011)CrossRef L.A. Beaupre, D.W. Morrish, D.A. Hanley, W.P. Maksymowych, N.R. Bell, A.G. Juby, S.R. Majumdar, Oral bisphosphonates are associated with reduced mortality after hip fracture. Osteoporos. Int. 22, 983–991 (2011)CrossRef
12.
Zurück zum Zitat J.R. Center, D. Bliuc, N.D. Nguyen, T.V. Nguyen, J.A. Eisman, Osteoporosis medication and reduced mortality risk in elderly women and men. J. Clin. Endocrinol. Metab. 96, 1006–1014 (2014)CrossRef J.R. Center, D. Bliuc, N.D. Nguyen, T.V. Nguyen, J.A. Eisman, Osteoporosis medication and reduced mortality risk in elderly women and men. J. Clin. Endocrinol. Metab. 96, 1006–1014 (2014)CrossRef
13.
Zurück zum Zitat P.N. Sambrook, I.D. Cameron, J.S. Chen, L.M. March, J.M. Simpson, R.G. Cumming, M.J. Seibel, Oral bisphosphonates are associated with reduced mortality in frail older people: a prospective five-year study. Osteoporos. Int. 22, 2551–2556 (2011)CrossRef P.N. Sambrook, I.D. Cameron, J.S. Chen, L.M. March, J.M. Simpson, R.G. Cumming, M.J. Seibel, Oral bisphosphonates are associated with reduced mortality in frail older people: a prospective five-year study. Osteoporos. Int. 22, 2551–2556 (2011)CrossRef
14.
Zurück zum Zitat P. Lee, C. Ng, A. Slattery, P. Nair, J.A. Eisman, J.R. Center, Preadmission bisphosphonate and mortality in critically ill patients. J. Clin. Endocrinol. Metab. 101, 1945–1953 (2016)CrossRef P. Lee, C. Ng, A. Slattery, P. Nair, J.A. Eisman, J.R. Center, Preadmission bisphosphonate and mortality in critically ill patients. J. Clin. Endocrinol. Metab. 101, 1945–1953 (2016)CrossRef
15.
Zurück zum Zitat S.R. Cummings, L.Y. Lui, R. Eastell, I.E. Allen, Association between drug treatments for patients with osteoporosis and overall mortality rates: a meta-analysis. JAMA Intern. Med. 179, 1491–1500 (2019)CrossRef S.R. Cummings, L.Y. Lui, R. Eastell, I.E. Allen, Association between drug treatments for patients with osteoporosis and overall mortality rates: a meta-analysis. JAMA Intern. Med. 179, 1491–1500 (2019)CrossRef
16.
Zurück zum Zitat M.D. Neuman, J.H. Silber, J.S. Magaziner, M.A. Passarella, S. Mehta, R.M. Werner, Survival and functional outcomes after hip fracture among nursing home residents. JAMA Intern. Med. 174, 1273–1280 (2014)CrossRef M.D. Neuman, J.H. Silber, J.S. Magaziner, M.A. Passarella, S. Mehta, R.M. Werner, Survival and functional outcomes after hip fracture among nursing home residents. JAMA Intern. Med. 174, 1273–1280 (2014)CrossRef
17.
Zurück zum Zitat L.A. Beaupre, S.R. Majumdar, S. Dieleman, A. Au, D.W. Morrish, Diagnosis and treatment of osteoporosis before and after admission to long-term care institutions. Osteoporos. Int. 23, 573–580 (2011)CrossRef L.A. Beaupre, S.R. Majumdar, S. Dieleman, A. Au, D.W. Morrish, Diagnosis and treatment of osteoporosis before and after admission to long-term care institutions. Osteoporos. Int. 23, 573–580 (2011)CrossRef
18.
Zurück zum Zitat S. Parikh, H. Mogun, J. Avorn, D.H. Solomon, Osteoporosis medication use in nursing home patients with fractures in 1 US state. Arch. Intern. Med. 168, 1111–1115 (2008)CrossRef S. Parikh, H. Mogun, J. Avorn, D.H. Solomon, Osteoporosis medication use in nursing home patients with fractures in 1 US state. Arch. Intern. Med. 168, 1111–1115 (2008)CrossRef
19.
Zurück zum Zitat A. Nobili, G. Licata, F. Salerno, L. Pasina, M. Tettamanti, C. Franchi, L. De Vittorio, A. Marengoni, S. Corrao, A. Iorio, M. Marcucci, P.M. Mannucci; SIMI Investigators, Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study. Eur. J. Clin. Pharmacol. 67, 507–519 (2011)CrossRef A. Nobili, G. Licata, F. Salerno, L. Pasina, M. Tettamanti, C. Franchi, L. De Vittorio, A. Marengoni, S. Corrao, A. Iorio, M. Marcucci, P.M. Mannucci; SIMI Investigators, Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study. Eur. J. Clin. Pharmacol. 67, 507–519 (2011)CrossRef
20.
Zurück zum Zitat F. Salvi, V. Morichi, A. Grilli, R. Giorgi, L. Spazzafumo, S. Polonara, G. De Tommaso, A. Rappelli, P. Dessì-Fulgheri, A geriatric emergency service for acutely ill elderly patients: pattern of use and comparison with a conventional emergency department in Italy. J. Am. Geriatr. Soc. 56, 2131–2138 (2008)CrossRef F. Salvi, V. Morichi, A. Grilli, R. Giorgi, L. Spazzafumo, S. Polonara, G. De Tommaso, A. Rappelli, P. Dessì-Fulgheri, A geriatric emergency service for acutely ill elderly patients: pattern of use and comparison with a conventional emergency department in Italy. J. Am. Geriatr. Soc. 56, 2131–2138 (2008)CrossRef
21.
Zurück zum Zitat P.A. Parmelee, P.D. Thuras, I.R. Katz, M.P. Lawton, Validation of the cumulative illness rating scale in a geriatric residential population. J. Am. Geriatr. Soc. 43, 130–137 (1995)CrossRef P.A. Parmelee, P.D. Thuras, I.R. Katz, M.P. Lawton, Validation of the cumulative illness rating scale in a geriatric residential population. J. Am. Geriatr. Soc. 43, 130–137 (1995)CrossRef
22.
Zurück zum Zitat S. Shah, F. Vanclay, B. Cooper, Improving the sensitivity of the Barthel index for stroke rehabilitation. J. Clin. Epidemiol. 42, 703–709 (1989)CrossRef S. Shah, F. Vanclay, B. Cooper, Improving the sensitivity of the Barthel index for stroke rehabilitation. J. Clin. Epidemiol. 42, 703–709 (1989)CrossRef
23.
Zurück zum Zitat R. Katzman, T. Brown, P. Fuld, A. Peck, R. Schechter, H. Schimmel, Validation of a short orientation-memory-concentration test of cognitive impairment. Am. J. Psychiatry 140, 734–739 (1983)CrossRef R. Katzman, T. Brown, P. Fuld, A. Peck, R. Schechter, H. Schimmel, Validation of a short orientation-memory-concentration test of cognitive impairment. Am. J. Psychiatry 140, 734–739 (1983)CrossRef
24.
Zurück zum Zitat C. Hickie, J. Snowdon, Depression scales for the elderly: GDS, Gilleard, Zung. Clin. Gerontol. J. Aging Ment. Health 6, 51–53 (1987) C. Hickie, J. Snowdon, Depression scales for the elderly: GDS, Gilleard, Zung. Clin. Gerontol. J. Aging Ment. Health 6, 51–53 (1987)
25.
Zurück zum Zitat R. Nuti, M.L. Brandi, G. Checchia, O. Di Munno, L. Dominguez, P. Falaschi, C.E. Fiore, G. Iolascon, S. Maggi, R. Michieli, S. Migliaccio, S. Minisola, M. Rossini, G. Sessa, U. Tarantino, A. Toselli, G.C. Isaia, Guidelines for the management of osteoporosis and fragility fractures. Intern. Emerg. Med. 14, 85–102 (2019)CrossRef R. Nuti, M.L. Brandi, G. Checchia, O. Di Munno, L. Dominguez, P. Falaschi, C.E. Fiore, G. Iolascon, S. Maggi, R. Michieli, S. Migliaccio, S. Minisola, M. Rossini, G. Sessa, U. Tarantino, A. Toselli, G.C. Isaia, Guidelines for the management of osteoporosis and fragility fractures. Intern. Emerg. Med. 14, 85–102 (2019)CrossRef
26.
Zurück zum Zitat C. Cipriani, J. Pepe, F. Bertoldo, G. Bianchi, F.P. Cantatore, A. Corrado, M. Di Stefano, B. Frediani, D. Gatti, A. Giustina, T. Porcelli, G. Isaia, M. Rossini, L. Nieddu, S. Minisola, G. Girasole, M. Pedrazzoni, The epidemiology of osteoporosis in Italian postmenopausal women according to the National Bone Health Alliance (NBHA) diagnostic criteria: a multicenter cohort study. J. Endocrinol. Investig. 41, 431–438 (2018)CrossRef C. Cipriani, J. Pepe, F. Bertoldo, G. Bianchi, F.P. Cantatore, A. Corrado, M. Di Stefano, B. Frediani, D. Gatti, A. Giustina, T. Porcelli, G. Isaia, M. Rossini, L. Nieddu, S. Minisola, G. Girasole, M. Pedrazzoni, The epidemiology of osteoporosis in Italian postmenopausal women according to the National Bone Health Alliance (NBHA) diagnostic criteria: a multicenter cohort study. J. Endocrinol. Investig. 41, 431–438 (2018)CrossRef
27.
Zurück zum Zitat P. Donato, J. Pepe, L. Colangelo, V. Danese, V. Cecchetti, S. Minisola, C. Cipriani, Adherence to bisphosphonates in the general population: a retrospective study in patients referred to a primary care service. Arch. Osteoporos. 14, 42 (2019)CrossRef P. Donato, J. Pepe, L. Colangelo, V. Danese, V. Cecchetti, S. Minisola, C. Cipriani, Adherence to bisphosphonates in the general population: a retrospective study in patients referred to a primary care service. Arch. Osteoporos. 14, 42 (2019)CrossRef
28.
Zurück zum Zitat J. Pepe, C. Cipriani, V. Cecchetti, C. Ferrara, G. Della Grotta, V. Danese, L. Colangelo, S. Minisola, Patients’ reasons for adhering to long-term alendronate therapy. Osteoporos. Int. 30, 1627–1634 (2019)CrossRef J. Pepe, C. Cipriani, V. Cecchetti, C. Ferrara, G. Della Grotta, V. Danese, L. Colangelo, S. Minisola, Patients’ reasons for adhering to long-term alendronate therapy. Osteoporos. Int. 30, 1627–1634 (2019)CrossRef
29.
Zurück zum Zitat C. Mao, F.R. Li, Z.X. Yin, Y.B. Lv, J.S. Luo, J.Q. Yuan, F. Mhungu, J.N. Wang, W.Y. Shi, J.H. Zhou, G.C. Chen, X. Gao, V.B. Kraus, X.B. Wu, X.M. Shi, Plasma 25-Hydroxyvitamin D concentrations are inversely associated with all-cause mortality among a prospective cohort of Chinese adults aged ≥80 years. J. Nutr. 149, 1056–1064 (2019)CrossRef C. Mao, F.R. Li, Z.X. Yin, Y.B. Lv, J.S. Luo, J.Q. Yuan, F. Mhungu, J.N. Wang, W.Y. Shi, J.H. Zhou, G.C. Chen, X. Gao, V.B. Kraus, X.B. Wu, X.M. Shi, Plasma 25-Hydroxyvitamin D concentrations are inversely associated with all-cause mortality among a prospective cohort of Chinese adults aged ≥80 years. J. Nutr. 149, 1056–1064 (2019)CrossRef
30.
Zurück zum Zitat F. Fatoye, P. Smith, T. Gebrye, G. Yeowell, Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review. BMJ Open 9(4), e027049 (2019)CrossRef F. Fatoye, P. Smith, T. Gebrye, G. Yeowell, Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review. BMJ Open 9(4), e027049 (2019)CrossRef
Metadaten
Titel
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register)
verfasst von
Jessica Pepe
Pasquale Agosti
Cristiana Cipriani
Mauro Tettamanti
Alessandro Nobili
Luciano Colangelo
Rachele Santori
Mirella Cilli
Salvatore Minisola
Reposi investigators
Publikationsdatum
12.01.2021
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2021
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-020-02553-5

Weitere Artikel der Ausgabe 2/2021

Endocrine 2/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.